Cdk1/2/3 Polyclonal Antibody

CDK2 encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. Cyclin dependent kinase 2 is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants.

Introducing the CDK5 Activator-binding C42 Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate the study of CDK5 activation and its associated biological processes. This high-quality antibody has been meticulously developed and rigorously tested to ensure optimal performance and reliability in a wide range of applications.

The CDK5 Activator-binding C42 Polyclonal Antibody is specifically designed to target and bind to the CDK5 activator, a crucial protein involved in the regulation of neuronal development, synaptic plasticity, and neurodegenerative diseases. By selectively recognizing and binding to the CDK5 activator, this antibody enables researchers to investigate the intricate mechanisms underlying CDK5 activation and its impact on cellular processes.

Crafted with utmost precision, this polyclonal antibody exhibits exceptional specificity and sensitivity, allowing for accurate and reliable detection of the CDK5 activator in various experimental settings. Its superior affinity ensures robust and consistent results, enabling researchers to obtain valuable insights into the intricate workings of CDK5 activation.

The CDK5 Activator-binding C42 Polyclonal Antibody is compatible with a diverse range of techniques, including Western blotting, immunoprecipitation, immunofluorescence, and immunohistochemistry. Its versatility empowers researchers to explore CDK5 activation in different cellular contexts and unravel its role in various physiological and pathological conditions.

Furthermore, this antibody has been extensively validated using rigorous quality control measures to guarantee its performance and reproducibility. Each batch is subjected to stringent testing to ensure batch-to-batch consistency, providing researchers with reliable and consistent results throughout their experiments.

In summary, the CDK5 Activator-binding C42 Polyclonal Antibody is a state-of-the-art scientific tool that offers unparalleled specificity, sensitivity, and versatility in the study of CDK5 activation. With its exceptional performance and reliability, this antibody is poised to revolutionize research in the field of neurobiology, neurodegenerative diseases, and beyond.